In 1986 a prospective multicenter observation trial in patients with resected gastric cancer was initiated in Germany. An analysis of prognostic factors based on the 1 0-year survival data is now presented.
Patients and Methods
A total of 1654 patients treated for gastric cancer between 1986 and 1989 at 19 centers in Germany and Austria were included. The resected specimen were evaluated histopathologically according to a standardized protocol. The extent of lymphadenectomy was classified after surgery based on the number of removed lymph nodes on histopathologic assessment (25 or fewer removed nodes, Dl or standard lymphadenectomy; >25 removed nodes, D2 or extended lymphadenectomy). Endpoint of the study was death. Follow-up is complete for 97% of the included patients (median follow-up of the surviving patients is 8.4 years). Prognostic factors were assessed by multivariate analysis.
Results
A complete macroscopic and microscopic tumor resection (RO resection according to the UICC 1997) could be achieved in 1 182 of the 1654 patients (71.5%). The calculated 10-year survival rate in the entire patient population was 26.3% + 4.7%; it was 36.1% ± 1.6% after an RO resection. In the total patient population there was an independent prognostic effect of the ratio between invaded and removed lymph nodes, the residual tumor (R) category, the pT category, the presence of postsurgical complications, and the presence of distant metastases. Multivariate analysis in the subgroup of patients who had a UICC RO resection confirmed the nodal status, the pT category, and the presence of postsurgical complications as the major independent prognostic factors. The extent of lymph node dissection had a significant and independent effect on the 1 0-year survival rate in patients with stage 11 tumors. This effect was present in the subgroups with (pT2N1) and without (pT3NO) lymph node metastases on standard histopathologic assessment. The beneficial effect of extended lymph node dissection for stage 11 tumors persisted when patients with insufficient lymph node dissection (<15 nodes) were excluded from the analysis. There was no difference in the postsurgical morbidity and mortality rates between patients with standard and extended lymph node dissection.
Conclusions
Lymph node ratio and lymph node status are the most important prognostic factors in patients with resected gastric cancer. In experienced centers, extended lymph node dissection does not increase the mortality or morbidity rate of resection for gastric cancer but markedly improves long-term survival in patients with stage 11 tumors. This effect appears to be independent of the phenomenon of stage migration.
The prognosis of patients with gastric carcinoma is determined by a series of tumor-and patient-associated fac-tors.1-3 Of particular interest are prognostic factors that may be influenced by therapeutic measures (i.e., the extent of resection and lymphadenectomy). Ideally, as many prognostic factors as possible should be known before beginning therapy so that therapy can be tailored to each patient. A The extent of the lymph node dissection was objectively evaluated by the pathologist by a careful count of the removed lymph nodes. In addition, the ratio between the number of positive lymph nodes and the number of removed nodes was calculated. The participating pathologists had agreed to a uniform assessment and documentation of the specimen. All histopathologic data and the presence and extent of residual tumor were determined according to the guidelines of the UICC.9-' A UICC RO resection was defined as a resection that resulted in complete macroscopic and microscopic tumor removal on intraoperative and histopathologic evaluation. [9] [10] [11] Although all participating surgeons agreed to perform a lymph node dissection of compartments I and II as described above, an adequate lymph node dissection was not achieved in a substantial portion of the patients. This was objectively demonstrated by a count of the removed lymph nodes. The histopathologic examination by the pathologists thus served as a quality control of the extent of the lymph node dissection. This situation provided the unique opportunity to compare the results of a more and less extensive lymph node dissection in patients with gastric carcinoma.
As a consequence of the lack of a good and practical definition, the extent of lymph node dissection was defined according to anatomic investigations of the expected number of lymph nodes in compartments I and 11.12 Based on these studies, an extirpation of more than 25 Tables 1 and 2 show the demographic data and the distribution of the data assessed for their prognostic impact in the entire patient The 30-and 90-day mortality rates in the total patient population were 5.1% and 10.6%, respectively. There were no significant differences in the 30-and 90-day mortality rates and the postsurgical complications between patients with standard and extended lymph node dissections (see Table 2 ).
The calculated 10-year survival rate was 26.3% ± 4.7% in the total patient population (Fig. 1 ) and 36.1% ± 1.6% in those with an RO resection. The prognostic factors identified by multiple stepwise regression analysis in the entire population with resected gastric cancer are ranked in Table 3 . The ratio between invaded and removed lymph nodes was identified as the single most important independent prognostic factor (p < 0.0001, Fig. 2) , followed by the residual tumor (R) category (p < 0.0001, Fig. 3 ), the pT category (p < 0.0001), postsurgical complications (p < 0.0001), and the presence of distant metastases (p < 0.0001).
Multivariate analysis of the subgroup of patients who had a UICC RO resection confirmed nodal status as the single most important independent prognostic factor (p < 0.0001). This was followed by the pT category (p < 0.0001), postsurgical complications (p < 0.001), distant metastases (p = 0.0023), and tumor diameter (p = 0.0002) ( Table 4) . Nodal status, the pT category, and the presence of multiple postsurgical complications persisted as independent predictors of survival when postsurgical deaths were excluded.
The distribution of the demographic data and the potential prognostic factors in patients with a standard and extended lymph node dissection is shown in Table 2 . There was no significant difference in the UICC stage distribution between the two groups, provided only patients with adequate lymph node staging (i.e., >15 removed nodes) were long-term survival in the entire population with resected gastric cancer, the patients with RO resection (Fig. 4) , and the subgroups of patients with tumor stages IA, IB, IIIA, IIIB, and IV. The median survival time and the 5-and 10-year survival rates for the individual UICC tumor stages and pTN categories in patients with standard and extensive lymph node dissection are listed in Tables 6 and 7 . In patients with RO stage II tumors, extended lymph node dissection markedly (Fig. 5) .
When assessed according to the pTN categories, a significant prognostic benefit of extended lymph node dissection was present in the UICC stage II subgroups with (pT2N1, Fig. 6) and without (pT3NO, Fig. 7 ) lymph node metastases on standard histopathologic assessment.
DISCUSSION
Complete locoregional tumor removal with adequate margins of clearance (i.e., an RO resection according to the UICC classification) has been repeatedly identified and widely accepted as a major factor for reduction of locoregional tumor recurrences and improvement of survival time in patients with gastric cancer. -4,18-20 Systematic lymph node dissection is used in an attempt to make surgical therapy for gastric carcinoma even more radical to prolong survival.5'21-24 The present evaluation of the long-term outcome of patients in the German Gastric Carcinoma Study (GGCS)4,5 identified the lymph node ratio (i.e., the ratio of positive to removed nodes) and the residual tumor (R) category as the major independent prognostic factors in patients with resected gastric cancer. In addition, the study shows that extended lymph node dissection is the most important factor determining long-term survival in patients with stage II gastric cancer.
A reliable assessment of prognostic factors in patients with resected gastric cancer can be made only in a large group of patients with homogeneous treatment, a standardized histopathologic assessment of the specimen, and longterm follow-up; such a situation is found in the GGCS. Inconsistencies usually associated with a multicenter trial were minimized by a series of consensus meetings. The large number of patients allowed a multivariate analysis to identify the frequently interrelated factors that independently influence survival, and permitted analysis of subgroups.17 The quality and extent of lymphadenectomy were determined objectively by the pathologist. The precondition for this quality control was an en bloc resection that resulted in a single specimen with attached lymph nodes. This not only permitted a count of the removed lymph nodes but also allowed assessment of their anatomic location. Lymph node dissection was standardized extensively at the participating centers before patient enrollment. Nevertheless, the aim of an adequate D2 lymphadenectomy (i.e., removal of >25 lymph nodes) was achieved in only 66.3% of the patients. Although the GGCS was not designed as a randomized trial, this situation provided the unique opportunity to evaluate the prognostic impact of less and more radical lymphadenectomy in patients with gastric cancer.
Similar to several randomized trials,2428 the long-term Figure 4 . Cumulative survival in patients with RO resection: effect of Dl and D2 lymph node dissection.
standard lymphadenectomy to 49.2% with extended lymphadenectomy. Because patients with UICC stage II tumors constitute only 15% to 20% of the patients who undergo resection for gastric cancer in the Western world, even a marked improvement in the prognosis in this small subgroup will not significantly affect the overall prognosis of patients with resected gastric cancer. An improvement of the long-term survival rate from 20% to 50% in patients with stage II tumors translates into an increase of less than 5% in the overall long-term survival rate of patients with resected gastric cancer. Well more than 1000 patients would have to be randomized to detect such a marginal change in the overall prognosis with a power of 90% at a significance level of 0.05. The number of patients in none of the published randomized studies is large enough to detect this effect. Consequently, a beneficial effect of extended lymphadenectomy has so far been shown only in analyses of subgroups, as performed in the present study.
When the patients with UICC stage II tumors were analyzed according to the individual pTN subgroups, a survival benefit for extended lymphadenectomy could be shown in patients in pNO and pNl categories (pT2N1 and pT3NO). This indicates that lymphadenectomy is beneficial not only in patients with frank lymph node metastases but also in patients in whom no lymph node metastases can be detected by standard histopathologic assessment. The benefit of rad- term survival particularly in patients with incipient lymph node metastases.
The ratio between positive and removed nodes is a simple measure of the efficacy of lymphadenectomy and constituted the most important independent prognostic factor in patients with an RO resection. Similar to the data reported by Okusa et al.,0 the results of our study show a significant deterioration of the prognosis when more than 20% of the removed lymph nodes were invaded by tumor. This implies that the prognosis of patients with only a few lymph node metastases can be improved by extending the lymph node dissection and thus reducing the ratio of invaded to removed nodes.
Reliable tumor staging is a prerequisite for a scientific approach to the problem of lymphadenectomy. Because a more radical lymph node dissection also allows more accurate staging, extended lymphadenectomy may result in a higher prevalence of patients with lymph node metastases, thus biasing the results of any comparison between various extents of lymph node dissection. This problem has been termed "stage migration" and has become an important 
